✓ Medically Reviewed Monograph

Solifenacin Succinate

Also known as / Synonyms: Solifenacin, M3 Antimuscarinic, OAB Antispasmodic

Bladder-selective antispasmodic tablet that calms bladder muscle spasms to stop urinary urgency, leakage, and frequent bathroom trips.

🩺
Reviewed by Dr. Lisa M., PharmD
Chief Clinical Editor · Updated November 19, 2026 · Editorial & Fact-Checking Policy
CDSCO & FDA Aligned
📋

Clinical Snapshot & Specifications

Generic Name: Solifenacin Succinate
Active Ingredient: Solifenacin Succinate
Dosage Form: Tablet
Available Strengths: 5 mg, 10 mg film-coated tablets
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Oral
Popular Verified Brands:
Solicept Vesicare Solitral Bispec (India)
Regulatory Standards: Approved by CDSCO; Schedule H prescription drug in India. US FDA and EMA approved for overactive bladder.
🎯

Approved Indications & Medical Uses

  • Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
  • Neurogenic detrusor overactivity in patients with spinal cord injury or multiple sclerosis.
  • Provides relative selectivity for muscarinic M3 receptors in the bladder detrusor muscle, reducing uninhibited detrusor contractions.
🚫

Contraindications (Do Not Use If…)

  • Urinary retention or severe bladder outflow obstruction.
  • Gastric retention or severe gastrointestinal motility disorders (toxic megacolon, severe ulcerative colitis).
  • Uncontrolled narrow-angle (angle-closure) glaucoma.
  • Known hypersensitivity to solifenacin succinate.
  • Severe hepatic impairment (Child-Pugh Class C).
🛡️

Important Clinical Precautions & Warnings

  • Urinary retention risk: monitor patients with clinically significant bladder outflow obstruction; may precipitate acute urinary retention requiring catheterization.
  • Narrow-angle glaucoma: use with caution in patients treated for narrow-angle glaucoma; antimuscarinics can increase intraocular pressure.
  • Decreased gastrointestinal motility: use caution in patients with severe constipation or ulcerative colitis.
  • Central nervous system effects and heat prostration: causes somnolence, blurred vision, and dizziness; impairs thermoregulation by reducing sweating, increasing heatstroke risk in hot climates.
  • QTc prolongation: high doses (30 mg) can prolong the QTc interval; use caution in patients with congenital long QT syndrome or hypokalemia.
  • Renal/hepatic dose ceiling: do not exceed 5 mg daily in severe renal impairment (CrCl < 30 mL/min) or moderate hepatic impairment (Child-Pugh B).

Special Populations (Paediatric & Geriatric Care)

Pediatric: Safety and efficacy have not been established in children. Geriatric: Safe in elderly patients with OAB; monitor for anticholinergic cognitive impairment, confusion, and constipation.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Dry mouth (xerostomia - most frequent), constipation, blurred vision, dyspepsia, urinary tract infection, dizziness, and fatigue.

🚨 Serious Side Effects — Seek Urgent Medical Care

Acute urinary retention, acute angle-closure glaucoma, severe paralytic ileus, angioedema with airway obstruction, and QTc interval prolongation.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin): significantly increase solifenacin AUC; do not exceed 5 mg daily when co-administered.
  • Other anticholinergic medications (ipratropium, amitriptyline, antihistamines): additive anticholinergic side effects (severe dry mouth, constipation, confusion).
  • Cholinesterase inhibitors (donepezil): solifenacin may antagonize cognitive benefits of acetylcholinesterase inhibitors.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies did not show teratogenic effects at maternal therapeutic exposures. Use during pregnancy only if potential benefit justifies potential fetal risk.

Lactation & Breastfeeding:

Use with caution — see notes

Solifenacin is excreted into animal milk; presence in human breast milk is unknown. Because of the potential for anticholinergic adverse effects in nursing infants, evaluate whether to discontinue nursing or the drug.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store tablets at 20°C to 25°C (68°F to 77°F). Protect from moisture.

⏱️ Missed Dose Protocol:

Take the missed dose as soon as remembered on the same day. If close to the next scheduled daily dose, skip and resume regular schedule. Do not take more than one tablet per day.

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.